We reviewed 50 GLP-1 telehealth providers and evaluated pricing structure, medication access, membership requirements, and service quality across every major platform in 2026.

Embody charges $299–$349/month for semaglutide or tirzepatide at any dose. PlexusDx charges $189–$289/month month-to-month for the same compounds. Both maintain flat pricing through dose escalation; PlexusDx offers oral alternatives and prepaid rates; Embody offers a 6-month guarantee.

PlexusDx offers month-to-month compounded semaglutide at $189/mo with no membership; Found bills $289/mo every 4 weeks (13 charges/year) and offers an insurance-supported track that PlexusDx does not.

BrightMeds undercuts PlexusDx on both semaglutide and tirzepatide injections, saving $60–$140 per month on standard plans. We break down pricing, prepay requirements, and service features using verified rates captured September 2026.

Six providers offer compounded semaglutide with no separate membership fee in 2026. PlexusDx, Peak Wellness, Henry Meds, Embody, Found, and TrimRx bill medication only; Eden requires a $99/month membership on top of its $99/month medication price.

We attempted to compare Peak Wellness and Zealthy GLP-1 programs but could not verify Zealthy's pricing or terms at checkout. Here's what the available evidence shows and where it falls short.

Peak Wellness publishes pricing and operating details; BetterMe Rx does not. Without verified rates, inclusions, or cancellation terms for BetterMe Rx, we can't calculate total cost or confirm what you're committing to.

Embody offers month-to-month injectable semaglutide and tirzepatide with 24/7 chat and a money-back guarantee. Henry Meds offers injectable and oral semaglutide plus oral tirzepatide with lower committed-term rates.

Found bills every 4 weeks and emphasizes coaching; Henry Meds ships every 45 days and offers oral semaglutide. This comparison covers month-to-month rates, prepaid totals, format differences, and 12-month cost calculations across three providers.

Embody and Fridays both deliver compounded semaglutide and tirzepatide with unlimited provider access, but their prices, support models, and guarantees differ in decision-critical ways. We compare month-to-month rates, coaching inclusions, and 12-month totals using verified July 2026 data.

Embody charges $299/month semaglutide with a 6-month guarantee; Found offers insurance billing and 12-month prepaid cash; PlexusDx runs $189/month semaglutide month-to-month. Three models, different fits.

Embody publishes standard-dose prices upfront at $299–$349/month. Remedy Meds shows microdose pricing ($189/month) only after intake. PlexusDx lists both tiers with committed-term options: $129/month for microdose and $189/month for semaglutide injection, month-to-month.

Starting tirzepatide for weight loss requires understanding how dosing progresses and what to expect in your first weeks. PlexusDx provides personalized tirzepatide injection therapy with flexible dosing adjusted to your individual response, at $289/mo month-to-month, or from $249/mo on the 6-month plan.

Insurance coverage for Wegovy remains limited for most patients, even though semaglutide is FDA-approved. PlexusDx provides personalized compounded semaglutide injections from licensed pharmacies, at $189/mo month-to-month, or from $149/mo on the 6-month plan, with no insurance required and HSA/FSA eligibility.

Mounjaro is manufactured by Eli Lilly for diabetes, but PlexusDx offers compounded tirzepatide injection—the same active compound—for weight loss at a fraction of the brand-name price, at $289/mo month-to-month, or from $249/mo on the 6-month plan with no insurance required.

Tirzepatide is a dual-action GLP-1 receptor agonist and GIP receptor agonist approved by the FDA for weight management. PlexusDx provides compounded tirzepatide injections from licensed 503A pharmacies, available nationwide without insurance requirements, at $289/mo month-to-month, or from $249/mo on the 6-month plan.

Tirzepatide typically shows appetite suppression within days, but meaningful weight loss emerges over weeks and months. PlexusDx explains the realistic timeline and how to maximize results with compounded tirzepatide injection therapy at $289/mo month-to-month, or from $249/mo on the 6-month plan.

Tirzepatide activates two hormone pathways to reduce appetite and improve metabolic control. PlexusDx offers compounded tirzepatide injections from licensed pharmacies, with personalized dosing based on your body's response—at $289/mo month-to-month, or from $249/mo on the 6-month plan.

BMI thresholds for GLP-1 medications like semaglutide depend on health conditions and individual factors. PlexusDx makes prescription semaglutide accessible to qualified patients with no insurance required, at $189/mo month-to-month, or from $149/mo on the 6-month plan.

Rising costs and access barriers have driven patients to seek tirzepatide outside conventional pharmacy systems. PlexusDx delivers compounded tirzepatide injection safely through licensed 503A pharmacies, at $289/mo month-to-month, or from $249/mo on the 6-month plan with no insurance required.

Mounjaro (tirzepatide) is only available as an injection, but oral GLP-1 alternatives like semaglutide offer effective weight loss without needles. PlexusDx provides compounded oral options at $289/mo month-to-month, or from $249/mo on the 6-month plan with genetic testing to optimize your treatment.

Tirzepatide injection offers a dual-action weight loss mechanism, and PlexusDx delivers compounded doses at $289/mo month-to-month, or from $249/mo on the 6-month plan with pricing that stays flat regardless of your therapeutic progression.

Tirzepatide delivers dual-action weight loss for men through GIP and GLP-1 receptor activation. Learn clinical outcomes, realistic timelines, and how PlexusDx personalizes your therapy at $289/mo month-to-month, or from $249/mo on the 6-month plan.

Mounjaro (tirzepatide) has not yet received FDA approval specifically for weight loss, though clinical trials show significant metabolic benefits. PlexusDx offers compounded tirzepatide injection as a personalized weight management option at $289/mo month-to-month, or from $249/mo on the 6-month plan.

Mounjaro received FDA approval for type 2 diabetes management, not weight loss treatment. PlexusDx provides access to compounded tirzepatide injection, a dual-action GLP-1 and GIP receptor agonist, at $289/mo month-to-month, or from $249/mo on the 6-month plan with no insurance required.

Semaglutide can deliver meaningful weight loss when combined with proper dosing strategies, nutrition planning, and activity increases. PlexusDx helps patients unlock their full therapeutic potential through personalized GLP-1 therapy at $189/mo month-to-month, or from $149/mo on the 6-month plan.

Tirzepatide users often notice appetite suppression within days, but measurable weight loss typically appears within 2–4 weeks. PlexusDx compounded tirzepatide injections help you reach your health goals faster with personalized dosing protocols at $289/mo month-to-month, or from $249/mo on the 6-month plan.

Semaglutide eligibility depends on your BMI, health history, and metabolic profile rather than a single qualifying condition. PlexusDx makes personalized semaglutide therapy accessible to all 50 states without insurance requirements, at $189/mo month-to-month, or from $149/mo on the 6-month plan.

Wegovy has transformed weight loss treatment by activating GLP-1 receptors to reduce hunger and regulate blood sugar. PlexusDx provides access to compounded semaglutide injections with similar mechanisms at a fraction of the cost, at $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance required.

DIY tirzepatide beverages circulating online promise weight loss without prescriptions, but lack scientific validation and medical supervision. PlexusDx delivers compounded tirzepatide injections from licensed 503A pharmacies with clinical support and transparent pricing at $289/mo month-to-month, or from $249/mo on the 6-month plan.